基于CNKI和PubMed数据库的大豆异黄酮和雌马酚研究现状分析
|
摘要
通过文献分析大豆异黄酮和雌马酚的最新研究进展能够为大豆异黄酮的深入研究和产品升级提供帮助和参考。本研究从CNKI数据库和PubMed在线网站下载以"大豆异黄酮"或"雌马酚"为主题的期刊文献分析数据。使用Excel进行数据分析和图表制作。分析结果表明大豆异黄酮和雌马酚相关文献主要发表在《大豆科学》、《卫生研究》和《The Journal of Nutrition》等期刊,主要分布在预防医学、食品营养与卫生学、生物学、药学和肿瘤学等学科。中文文献主要以提取、纯化和检测方法等研究为主,而外文文献报道与肿瘤、乳腺癌和营养代谢疾病等相关的文献较多。美国、中国和日本是发表大豆异黄酮和雌马酚文献的主要国家,但从研究机构来看,各研究单位研究侧重点存在一定的差异。值得深思的是2007年后,大豆异黄酮和雌马酚相关文献数量均急剧下降。虽然大豆异黄酮已有多年的研究历史,但关于雌马酚的研究还相对较少,还有待进一步研究,以便更好地提高传统大豆食品的营养和经济价值。
To analyze the published journal papers and to understand the latest research progress of soybean isoflavones and estradiol can provide help and reference for further research and product upgrading of soybean isoflavones. Data from CNKI database and Pub Med online analysis website was downloaded for literature analysis with the theme of ‘soy isoflavones' or‘equol'. We used Excelto analysisdata,preparate table and chartion. Soybean isoflavones and equol were mainly published in the journals of‘Soybean Science',‘Journal of Hygiene Research'and‘The Journal of Nutrition'. They were mostly distributed in the fields of preventive medicine,food nutrition and hygiene,biology,pharmacy and oncology. The Chinese literature mainly focuses on extraction,purification and detection methods research,while the foreign literature reportsare related to tumors,breast cancer,nutritional and metabolic diseases. The United States,China and Japan are the main countries publishing soy isoflavones and equol literature,but from the perspective of research institutions,the research focus of each research unit is somewhat different. It is worth pondering that after 2007,the article numbers of soy isoflavones and equol has decreased dramatically. Although soy isoflavones have been studied for many years,there are few studies on equol,and further studies are needed to improve the nutritional and economic value of traditional soybean food.
To analyze the published journal papers and to understand the latest research progress of soybean isoflavones and estradiol can provide help and reference for further research and product upgrading of soybean isoflavones. Data from CNKI database and Pub Med online analysis website was downloaded for literature analysis with the theme of ‘soy isoflavones' or‘equol'. We used Excelto analysisdata,preparate table and chartion. Soybean isoflavones and equol were mainly published in the journals of‘Soybean Science',‘Journal of Hygiene Research'and‘The Journal of Nutrition'. They were mostly distributed in the fields of preventive medicine,food nutrition and hygiene,biology,pharmacy and oncology. The Chinese literature mainly focuses on extraction,purification and detection methods research,while the foreign literature reportsare related to tumors,breast cancer,nutritional and metabolic diseases. The United States,China and Japan are the main countries publishing soy isoflavones and equol literature,but from the perspective of research institutions,the research focus of each research unit is somewhat different. It is worth pondering that after 2007,the article numbers of soy isoflavones and equol has decreased dramatically. Although soy isoflavones have been studied for many years,there are few studies on equol,and further studies are needed to improve the nutritional and economic value of traditional soybean food.
引文
[1]卢丞文,刘颖.大豆异黄酮生理功能的研究进展[J].农业与技术,2017,37(17):4-5.(Lu Z W,Liu Y. Research progresson physiological function of soybean isoflavones[J]. Agricultureand Technology,2017,37(17):4-5.)
[2] Messina M,Rogero M M,Fisberg M,et al. Health impact ofchildhood and adolescent soy consumption[J]. Nutrition Reviews,2017,75(7):500-515.
[3] Zaheer K,Humayoun A M. An updated review of dietary isofla-vones:Nutrition,processing,bioavailability and impacts on hu-man health[J]. Critical Reviews in Food Science and Nutrition,2017,57(6):1280-1293.
[4] Setchell K D,Brown N M,Zimmer-Nechemias L,et al. Evidencefor lack of absorption of soy isoflavone glycosides in humans,sup-porting the crucial role of intestinal metabolism for bioavailability[J]. The American Journal of Clinical Nutrition,2002,76(2):447-453.
[5] Nakajima N,Nozaki N,Ishihara K,et al. Analysis of isoflavonecontent in tempeh,a fermented soybean,and preparation of a newisoflavone-enriched tempeh[J]. Journal of Bioscience and Bioen-gineering,2005,100(6):685-687.
[6] Frankenfeld C L. Cardiometabolic risk and gut microbial phy-toestrogen metabolite phenotypes[J]. Molecular Nutrition&FoodResearch,2017,61(1),Doi:10. 1002/mnfr. 201500900.
[7] Setchell K D,Clerici C. Equol:History,chemistry,and forma-tion[J]. The Journal of Nutrition,2010,140(7):1355-1362.
[8] Setchell K D,Brown N M,Lydeking-Olsen E. The clinical impor-tance of the metabolite equol-a clue to the effectiveness of soy andits isoflavones[J]. The Journal of Nutrition,2002,132(12):3577-3584.
[9] Setchell K D,Clerici C. Equol:Pharmacokinetics and biologicalactions[J]. The Journal of Nutrition,2010,140(7):1363-1368.
[10] Bowey E,Adlercreutz H,Rowland I. Metabolism of isoflavonesand lignans by the gut microflora:A study in germ-free and humanflora associated rats[J]. Food and Chemical Toxicology,2003,41(5):631-636.
[11] Rowland I,Wiseman H,Sanders T,et al. Metabolism of oestro-gens and phytoestrogens:Role of the gut microflora[J]. Biochemi-cal Society Transactions,1999,27(2):304-308.
[12] Setchell K D,Zhao X,Shoaf S E,et al. The pharmacokinetics ofS-(-)equol administered as SE5-OH tablets to healthy postmeno-pausal women[J]. The Journal of Nutrition,2009,139(11):2037-2043.
[13] Setchell K D,Cole S J. Method of defining equol-producer statusand its frequency among vegetarians[J]. The Journal of Nutrition,2006,136(8):2188-2193.
[14] Rowland I R,Wiseman H,Sanders T A,et al. Interindividualvariation in metabolism of soy isoflavones and lignans:Influence ofhabitual diet on equol production by the gut microflora[J]. Nutri-tion and Cancer,2000,36(1):27-32.
[15] Song K B,Atkinson C,Frankenfeld C L,et al. Prevalence ofdaidzein-metabolizing phenotypes differs between Caucasian andKorean American women and girls[J]. The Journal of Nutrition,2006,136(5):1347-1351.
[16] Xiao Y,Zhang S,Tong H,et al. Comprehensive evaluation of therole of soy and isoflavone supplementation in humans and animalsover the past two decades[J]. Phytotherapy Research,2018,32(3):384-394.
[17]李海亮,邓颖,王欣,等.肠道微生物代谢产物-S-雌马酚与人类健康关系研究进展[J].中国微生态学杂志,2018,30(3):362-367.(Li H L,Deng Y,Wang X,et al. The relationship be-tween S-equol and human health:Research progress[J]. ChineseJournal of Microecology,2018,30(3):362-367.)
[2] Messina M,Rogero M M,Fisberg M,et al. Health impact ofchildhood and adolescent soy consumption[J]. Nutrition Reviews,2017,75(7):500-515.
[3] Zaheer K,Humayoun A M. An updated review of dietary isofla-vones:Nutrition,processing,bioavailability and impacts on hu-man health[J]. Critical Reviews in Food Science and Nutrition,2017,57(6):1280-1293.
[4] Setchell K D,Brown N M,Zimmer-Nechemias L,et al. Evidencefor lack of absorption of soy isoflavone glycosides in humans,sup-porting the crucial role of intestinal metabolism for bioavailability[J]. The American Journal of Clinical Nutrition,2002,76(2):447-453.
[5] Nakajima N,Nozaki N,Ishihara K,et al. Analysis of isoflavonecontent in tempeh,a fermented soybean,and preparation of a newisoflavone-enriched tempeh[J]. Journal of Bioscience and Bioen-gineering,2005,100(6):685-687.
[6] Frankenfeld C L. Cardiometabolic risk and gut microbial phy-toestrogen metabolite phenotypes[J]. Molecular Nutrition&FoodResearch,2017,61(1),Doi:10. 1002/mnfr. 201500900.
[7] Setchell K D,Clerici C. Equol:History,chemistry,and forma-tion[J]. The Journal of Nutrition,2010,140(7):1355-1362.
[8] Setchell K D,Brown N M,Lydeking-Olsen E. The clinical impor-tance of the metabolite equol-a clue to the effectiveness of soy andits isoflavones[J]. The Journal of Nutrition,2002,132(12):3577-3584.
[9] Setchell K D,Clerici C. Equol:Pharmacokinetics and biologicalactions[J]. The Journal of Nutrition,2010,140(7):1363-1368.
[10] Bowey E,Adlercreutz H,Rowland I. Metabolism of isoflavonesand lignans by the gut microflora:A study in germ-free and humanflora associated rats[J]. Food and Chemical Toxicology,2003,41(5):631-636.
[11] Rowland I,Wiseman H,Sanders T,et al. Metabolism of oestro-gens and phytoestrogens:Role of the gut microflora[J]. Biochemi-cal Society Transactions,1999,27(2):304-308.
[12] Setchell K D,Zhao X,Shoaf S E,et al. The pharmacokinetics ofS-(-)equol administered as SE5-OH tablets to healthy postmeno-pausal women[J]. The Journal of Nutrition,2009,139(11):2037-2043.
[13] Setchell K D,Cole S J. Method of defining equol-producer statusand its frequency among vegetarians[J]. The Journal of Nutrition,2006,136(8):2188-2193.
[14] Rowland I R,Wiseman H,Sanders T A,et al. Interindividualvariation in metabolism of soy isoflavones and lignans:Influence ofhabitual diet on equol production by the gut microflora[J]. Nutri-tion and Cancer,2000,36(1):27-32.
[15] Song K B,Atkinson C,Frankenfeld C L,et al. Prevalence ofdaidzein-metabolizing phenotypes differs between Caucasian andKorean American women and girls[J]. The Journal of Nutrition,2006,136(5):1347-1351.
[16] Xiao Y,Zhang S,Tong H,et al. Comprehensive evaluation of therole of soy and isoflavone supplementation in humans and animalsover the past two decades[J]. Phytotherapy Research,2018,32(3):384-394.
[17]李海亮,邓颖,王欣,等.肠道微生物代谢产物-S-雌马酚与人类健康关系研究进展[J].中国微生态学杂志,2018,30(3):362-367.(Li H L,Deng Y,Wang X,et al. The relationship be-tween S-equol and human health:Research progress[J]. ChineseJournal of Microecology,2018,30(3):362-367.)